AB Science announces that Health Canada has granted

PRESS RELEASE AB SCIENCE ANNOUNCES THAT HEALTH CANADA HAS GRANTED AUTHORIZATION TO FILE A NEW DRUG SUBMISSION FOR MASITINIB IN THE TREATMENT OF...

Related Keywords

United States ,Paris ,France General ,France ,Canada ,Canadians ,Canadian ,Arthur Rouill ,Scler Frontotemporal Degener ,Alain Moussy ,Kate Barrette ,Olivier Hermine ,Health Canada Adjudicating Committee ,Health Canada ,Scientific Committee ,New Drug Submission ,Advance Consideration ,Adjudicating Committee ,Des Sciences ,Lateral Scler Frontotemporal ,Adv Neurol Disord ,Euronext Paris ,Paris Stock Exchange Ab ,Ab Science ,Asitinib ,Ls ,Amyotrophic Lateral Sclerosis ,Eurology ,La ,Cl 233 Rose Lat Rale Amyotrophiqu ,Eurologie ,